Physician profile

Khaled Alabdallah

Cardiovascular Disease · Galveston, TX

NPI 1356832893

$10,555.63

in general payments reported to CMS, 2019-2025

16 companies · $7,505 in 2025

The $7,505 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,377.14
Travel and Lodging$5,178.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $4,151.64 2024-2025 Gallant, Ensite Precision, Ensite
Biotronik INC. $1,926.08 2025
Biosense Webster, INC. $1,710.71 2025 Carto 3
Boston Scientific Corporation $711.23 2023-2025 Advantio, Rotablator Rotational Atherectomy System Console Kit, Lux-Dx Insertable Cardiac Monitor
Abiomed $585.42 2023-2025 Impella
Janssen Pharmaceuticals, INC $215.77 2023-2024 Xarelto
Amgen INC. $199.54 2023-2024 Repatha
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $185.97 2024-2025 Lifevest
Impulse Dynamics (USA) INC. $175.87 2023 Optimizer
Edwards Lifesciences Corporation $152.92 2025
Medtronic, INC. $132.21 2023-2025 Selectsecure, Micra, Hvad Pump Implant Kit
Inspire Medical Systems, INC. $116.12 2024 Inspire
Teleflex LLC $109.58 2024 Turnpike
Pfizer INC. $94.11 2024
Philips North America LLC $67.99 2025 Igt Devices Systems Undivided
Show all 16 companies
CompanyGeneral paymentsYearsTop products
Lantheus Medical Imaging, INC. $20.47 2023 Definity

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Khaled Alabdallah

$10,555.63

in general payments reported 2019-2025

Years
2023-2025
Top company
Abbott Laboratories
Context
The $7,505 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/11258693/khaled-alabdallah

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.